Addex Therapeutics Ltd
ADXN
$7.10
-$0.2022-2.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.96M | 4.22M | 1.80M | 4.59M | 5.20M |
| Total Receivables | 611.50K | 686.00K | 249.50K | 179.60K | 408.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 232.40K | 309.60K | 722.30K | 257.70K | 672.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.80K | 8.70K | 878.30K | 1.00K | 500.00 |
| Total Current Assets | 4.82M | 5.22M | 3.65M | 5.03M | 6.28M |
|
|
|||||
| Total Current Assets | 4.82M | 5.22M | 3.65M | 5.03M | 6.28M |
| Net Property, Plant & Equipment | 53.10K | 32.70K | 35.80K | 419.10K | 372.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 25.70K | 81.10K | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.40K | 7.90K | 7.80K | 64.50K | -- |
| Total Assets | 14.41M | 15.24M | 3.70M | 5.51M | 6.71M |
|
|
|||||
| Total Accounts Payable | 385.70K | 336.50K | 1.80M | 1.17M | 426.20K |
| Total Accrued Expenses | 656.50K | 699.10K | 1.87M | 1.66M | 1.46M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.50K | 13.80K | 13.60K | 325.30K | 225.70K |
| Total Finance Division Other Current Liabilities | -- | -- | 1.47M | 279.10K | -- |
| Total Other Current Liabilities | -- | -- | 1.47M | 279.10K | -- |
| Total Current Liabilities | 1.05M | 1.05M | 5.16M | 3.44M | 2.11M |
|
|
|||||
| Total Current Liabilities | 1.05M | 1.05M | 5.16M | 3.44M | 2.11M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.30K | 22.00K | 25.40K | 83.60K | 127.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 215.40K | 92.50K | 35.00K | 632.70K | 159.40K |
| Total Liabilities | 1.31M | 1.16M | 5.22M | 4.15M | 2.40M |
|
|
|||||
| Common Stock & APIC | 317.54M | 298.50M | 297.36M | 318.31M | 290.71M |
| Retained Earnings | -416.90M | -390.19M | -402.98M | -428.02M | -391.00M |
| Treasury Stock & Other | 112.45M | 105.78M | 104.09M | 111.07M | 104.60M |
| Total Common Equity | 13.10M | 14.08M | -1.52M | 1.36M | 4.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.10M | 14.08M | -1.52M | 1.36M | 4.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.10M | 14.08M | -1.52M | 1.36M | 4.31M |
|
|
|||||
